Status:

WITHDRAWN

Fatigue in Patients With Amyotrophic Lateral Sclerosis

Lead Sponsor:

Cara Donohue

Conditions:

Amyotrophic Lateral Sclerosis

Dysphagia

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

Expiratory muscle strength training (EMST) is an emerging palliative intervention for prolonging pulmonary and swallow function in patients with amyotrophic lateral sclerosis (PALS), but it is unknown...

Detailed Description

This research proposal will determine the immediate impact of expiratory muscle strength training (EMST) on fatigue of the respiratory and swallowing musculature, whether objective decompensation tran...

Eligibility Criteria

Inclusion

  • Diagnosis of ALS defined as possible, probable, or definite by a neurologist using the El Escorial criteria
  • FVC\>65% predicted
  • adequate cognition as defined by a score of \>10 on the ALS Cognitive Behavioral Screen
  • adequate labial seal for completing pulmonary function tests and expiratory muscle strength training (EMST)
  • on a regular/thin liquid diet
  • no allergies to barium
  • not oxygen-dependent
  • no tracheostomy/ mechanical ventilation
  • no history of other neurological or respiratory disorders
  • no history of smoking
  • no history of head and neck cancer or other major head/neck surgery or radiation therapy.

Exclusion

  • FVC\<65% predicted
  • inadequate cognition as defined by a score of \<10 on the ALS Cognitive Behavioral Screen -inadequate labial seal for completing pulmonary function tests and expiratory muscle strength training (EMST)
  • not on a regular/thin liquid diet
  • allergies to barium
  • oxygen-dependent
  • presence of tracheostomy/dependent on mechanical ventilation
  • history of other neurological or respiratory disorders
  • history of smoking
  • history of head and neck cancer or other major head/neck surgery or radiation therapy.

Key Trial Info

Start Date :

February 10 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 10 2021

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04468191

Start Date

February 10 2021

End Date

February 10 2021

Last Update

February 15 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh Medical Center Presbyterian Hospital

Pittsburgh, Pennsylvania, United States, 15260